Email Us

The Disease Susceptibility Genetic Test-Anti-Cancer Package C CapitalBio

This test is based on biochip technology. By detecting TP53 (Tumor suppressor gene), CYP1A1 (Toxic metabolizing enzyme gene) and XRCC1 (DNA damage repair gene), assessing their impact on tumor risk, reminding customers to conduct comprehensive genetic testing, and helping customers with early prevention. Please feel free to contact us and get more information on personal genetic testing!

the disease susceptibility genetic test anti cancer package c

Features of the Disease Susceptibility Genetic Test-Anti-Cancer Package C

Test Content:

Male [11 items]Lung cancer, liver cancer, gastric cancer, esophageal cancer, colorectal cancer, bladder cancer, nasopharyngeal cancer, thyroid cancer, lymphoma, skin cancer, prostate cancer
Female [14 items]Lung cancer, liver cancer, gastric cancer, esophageal cancer, colorectal cancer, bladder cancer, nasopharyngeal cancer, thyroid cancer, lymphoma, breast cancer, cervical cancer, ovarian cancer, skin cancer, endometrial cancer



Applicable Population of the Disease Susceptibility Genetic Test-Anti-Cancer Package C

  • People with unhealthy eating habits, such as eating high-fat, high-calorie, pickled, smoked, fried foods.

  • People who smoke, who have been exposed to secondhand smoke for a long time, and who drink excessively.

  • People with irregular life and rest, long-term insomnia or staying up late, and lack of exercise.

  • People with long-term mental stress, anxiety, tension, or irritability.

  • Overweight or obese people.

Specifications of the Disease Susceptibility Genetic Test-Anti-Cancer Package C

Sample typesVenous blood / Oral swab
TAT9 working days


Products
Contact with CapitalBiotech
Contact Information
Your Inquiries (Expandable)
Instruments
Detection Kits/Reagents
Research Services
Biochip Design & Fabrication
Diagnostic Services
86-10-69002900
Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing